Published in Lancet on June 18, 1994
Cadmium in blood and urine--impact of sex, age, dietary intake, iron status, and former smoking--association of renal effects. Environ Health Perspect (2002) 2.62
Health and environment information systems for exposure and disease mapping, and risk assessment. Environ Health Perspect (2004) 1.41
Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ Health Perspect (2008) 1.24
Bone resorption and environmental exposure to cadmium in women: a population study. Environ Health Perspect (2008) 1.24
Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment. Occup Environ Med (2006) 1.15
Application of BMD approach to identify thresholds of cadmium-induced renal effect among 35 to 55 year-old women in two cadmium polluted counties in China. PLoS One (2014) 0.97
Cadmium, mercury, and lead in kidney cortex of the general Swedish population: a study of biopsies from living kidney donors. Environ Health Perspect (1999) 0.89
The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: a pilot study. Environ Health (2011) 0.88
Cadmium exposure and pancreatic cancer in south Louisiana. J Environ Public Health (2012) 0.88
Enzymuria in a population living near a cadmium battery plant. Occup Environ Med (1995) 0.83
Urinary neutral endopeptidase in workers exposed to cadmium: interaction with cigarette smoking. Occup Environ Med (1997) 0.82
Bone resorption and environmental exposure to cadmium in children: a cross--sectional study. Environ Health (2011) 0.82
Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis. Respir Res (2014) 0.80
Peripheral arterial disease and metals in urine and blood. Environ Health Perspect (2005) 0.77
Left Ventricular Structure and Function in Relation to Environmental Exposure to Lead and Cadmium. J Am Heart Assoc (2017) 0.76
Plasma cadmium and zinc and their interrelationship in adult Nigerians: potential health implications. Interdiscip Toxicol (2015) 0.75
Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet (1985) 8.35
Renal effects of cadmium body burden of the general population. Lancet (1990) 2.90
Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet (1978) 2.56
Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet (1986) 2.50
Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med (1992) 2.17
Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers. Lancet (2001) 2.13
Exposure to lead by the oral and the pulmonary routes of children living in the vicinity of a primary lead smelter. Environ Res (1980) 2.07
Epidemiological survey of workers exposed to cadmium. Arch Environ Health (1974) 1.95
Hemodynamic response to graded exercise after chronic beta-adrenergic blockade. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.85
In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine. Environ Res (1981) 1.81
Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man. Eur J Clin Pharmacol (1976) 1.80
Thrombolytic therapy with streptokinase using a standard dosage scheme. Br Med J (1966) 1.75
Lead and cadmium absorption among children near a nonferrous metal plant: a follow-up study of a test case. Environ Res (1978) 1.60
Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med (1992) 1.54
Beta-blockers: once or three times a day? Br Med J (1978) 1.54
Continuous-flow system for automation of latex immunoassay by particle counting. Clin Chem (1983) 1.52
Isolated systolic hypertension in the elderly. J Hypertens (1990) 1.48
Dose-response relations between urinary cadmium and tubular proteinuria in adult workers . Am J Ind Med (1997) 1.41
[Hemodynamic effects of urapidil in men]. Presse Med (1990) 1.41
Cadmium: exposure markers as predictors of nephrotoxic effects. Clin Chem (1994) 1.41
An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens (2002) 1.40
Health significance of cadmium induced renal dysfunction: a five year follow up. Br J Ind Med (1989) 1.39
Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens (1988) 1.39
Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem (1987) 1.36
Captopril and agranulocytosis. Lancet (1980) 1.36
Blood pressure and urinary cations in urban Bantu of Zaire. Am J Epidemiol (1986) 1.30
Noninvasive assessment of seasonal variations in cardiac structure and function in cyclists. Circulation (1983) 1.29
Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol (1981) 1.26
Exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study. Public Health and Environmental Exposure to Cadmium Study Group. Am J Hypertens (2000) 1.26
A meta-analysis of outcome trials in elderly hypertensives. J Hypertens (1992) 1.26
Measurement of urinary hippuric and m-methylhippuric acids by gas chromatography. Br J Ind Med (1973) 1.25
Investigations on the lung and kidney function in workers exposed to cadmium. Environ Health Perspect (1979) 1.24
Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. A metaanalysis of comparative studies. Am J Hypertens (1995) 1.23
Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22
Urinary cadmium and lead concentrations and their relation to blood pressure in a population with low exposure. Br J Ind Med (1984) 1.20
Prognostic significance of peak exercise capacity in patients with coronary artery disease. J Am Coll Cardiol (1994) 1.20
Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med (1993) 1.18
Characterization of the proteinuria in cadmium-exposed workers. Int Arch Occup Environ Health (1976) 1.18
Environmental exposure to cadmium and renal function of aged women in three areas of Belgium. Environ Res (1981) 1.17
Proteinuria: changes and mechanisms in toxic nephropathies. Crit Rev Toxicol (1991) 1.17
Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension (1988) 1.17
Early detection of the nephrotoxic effects of industrial chemicals: state of the art and future prospects. Am J Ind Med (1987) 1.17
Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med (1993) 1.16
Colorimetric determination of free fatty acids. Anal Biochem (1969) 1.16
The relationship between body weight and blood pressure. J Hum Hypertens (1988) 1.15
Four urinary cations and blood pressure. A population study in two Belgian towns. Am J Epidemiol (1983) 1.14
Hypotensive action and side effects of clonidine-chlorthalidone and methyldopa-chlorthalidone in treatment of hypertension. Br Med J (1970) 1.14
Comparison on the structure and transcriptional capability of growing phase and stationary yeast chromatin: a model for reversible gene activation. Nucleic Acids Res (1979) 1.14
The influence of menopause on blood pressure. J Hum Hypertens (1989) 1.13
Serum Clara cell protein: an indicator of bronchial cell dysfunction caused by tobacco smoking. Environ Res (1994) 1.12
Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study. Occup Environ Med (2000) 1.11
Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension. Br Heart J (1984) 1.11
Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br J Ind Med (1993) 1.10
Comparative hemodynamic studies in man of adrenergic bepta-1-receptors agents without (h 93/26 equal to metoprolol) or with (h 87/07) intrinsic sympathicomimetic activity. Acta Pharmacol Toxicol (Copenh) (1975) 1.10
Cardiac structure and function in cyclists and runners. Comparative echocardiographic study. Br Heart J (1984) 1.09
Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. Acta Med Scand (1981) 1.09
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients. Am Heart J (1982) 1.08
Carcinogenicity, teratogenicity and mutagenicity of arsenic. Mutat Res (1980) 1.08
Carcinogenicity and mutagenicity of chromium. Mutat Res (1980) 1.07
Outcome of recent thromboembolic occlusions of limb arteries treated with streptokinase. Br Med J (1970) 1.07
Health effects of environmental exposure to cadmium: objectives, design and organization of the Cadmibel Study: a cross-sectional morbidity study carried out in Belgium from 1985 to 1989. Environ Health Perspect (1990) 1.07
Salt and blood pressure in Belgium. J Epidemiol Community Health (1981) 1.06
Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery. Am J Cardiol (1995) 1.06
Reversibility of microproteinuria in cadmium workers with incipient tubular dysfunction after reduction of exposure. Am J Ind Med (1997) 1.03
The inheritance of left ventricular structure and function assessed by imaging and Doppler echocardiography. Am Heart J (1991) 1.03
Public health implications of environmental exposure to cadmium and lead: an overview of epidemiological studies in Belgium. Working Groups. J Cardiovasc Risk (1996) 1.03
Neurobehavioral functioning after cessation of manganese exposure: a follow-up after 14 years. Am J Ind Med (2007) 1.03
Heritability of aerobic power and anaerobic energy generation during exercise. J Appl Physiol (1985) (1991) 1.02
Characterization of cadmium proteinuria in man and rat. Environ Health Perspect (1984) 1.02
Letter: Beta receptors and renin release. N Engl J Med (1974) 1.02
The diurnal blood pressure profile. A population study. Am J Hypertens (1992) 1.02
Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients. Am Heart J (1976) 1.02
Relationship between blood level of atenolol and pharmacologic effect. Clin Pharmacol Ther (1977) 1.01
Muscle blood flow in normal and hypertensive subjects. Influence of age, exercise, and body position. Am Heart J (1969) 1.01
Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. Kidney Int (1976) 1.01
Transfer of cadmium from a sandy acidic soil to man: a population study. Environ Res (1992) 1.01
Influence of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors. Toxicology (1989) 1.00
Preliminary report on the haemodynamic response of hypertensive patients treated with a beta blocker (ICI 66082). Acta Clin Belg (1973) 1.00
Prognosis in low renin hypertension. N Engl J Med (1973) 0.99
Decrease of erythrocyte and glomerular membrane negative charges in chronic cadmium poisoning. Br J Ind Med (1988) 0.98
Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA). Br J Ind Med (1991) 0.98
Reference values for ambulatory blood pressure: a meta-analysis. J Hypertens Suppl (1990) 0.98
Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk (1994) 0.97
Response of free erythrocyte porphyrin and urinary delta-aminolevulinic acid in men and women moderately exposed to lead. Int Arch Arbeitsmed (1975) 0.97
Influence of hypertension on the hemodynamic response to exercise. Circulation (1967) 0.97
The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents. Postgrad Med J (1976) 0.97